Sei Investments Co. Has $17.05 Million Position in Prestige Consumer Healthcare Inc. $PBH

Key Points

• Sei Investments Co. increased its holdings in Prestige Consumer Healthcare Inc. by 3.2% in the first quarter, owning 215,271 shares valued at approximately $17.05 million.
• The company's quarterly earnings report revealed an EPS of $0.95, which was below analysts' expectations of $1.01, and a revenue decline of 6.6% year-over-year.
• Prestige Consumer Healthcare currently holds an average rating of "Hold" from analysts, with a consensus price target of $93.33 per share.

Sei Investments Co. raised its stake in Prestige Consumer Healthcare Inc. (NYSE:PBH - Free Report) by 3.2% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 215,271 shares of the company's stock after acquiring an additional 6,681 shares during the quarter. Sei Investments Co. owned approximately 0.43% of Prestige Consumer Healthcare worth $17,051,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently made changes to their positions in the company. Russell Investments Group Ltd. raised its holdings in Prestige Consumer Healthcare by 2.0% in the 1st quarter. Russell Investments Group Ltd. now owns 28,115 shares of the company's stock valued at $2,417,000 after buying an additional 561 shares during the last quarter. Resona Asset Management Co. Ltd. raised its holdings in Prestige Consumer Healthcare by 2.3% in the 1st quarter. Resona Asset Management Co. Ltd. now owns 9,105 shares of the company's stock valued at $783,000 after buying an additional 203 shares during the last quarter. Informed Momentum Co LLC bought a new position in Prestige Consumer Healthcare in the 1st quarter valued at approximately $3,559,000. Public Sector Pension Investment Board raised its holdings in Prestige Consumer Healthcare by 44.6% in the 1st quarter. Public Sector Pension Investment Board now owns 178,019 shares of the company's stock valued at $15,304,000 after buying an additional 54,926 shares during the last quarter. Finally, Nuveen LLC bought a new position in Prestige Consumer Healthcare in the 1st quarter valued at approximately $8,323,000. Institutional investors own 99.95% of the company's stock.

Prestige Consumer Healthcare Trading Up 0.5%

Shares of PBH stock traded up $0.2970 during trading hours on Tuesday, hitting $65.1670. 399,575 shares of the company were exchanged, compared to its average volume of 388,455. The firm has a market cap of $3.21 billion, a P/E ratio of 15.28, a P/E/G ratio of 2.05 and a beta of 0.43. Prestige Consumer Healthcare Inc. has a fifty-two week low of $62.95 and a fifty-two week high of $90.04. The company has a debt-to-equity ratio of 0.55, a quick ratio of 2.99 and a current ratio of 4.38. The company has a 50 day simple moving average of $76.85 and a two-hundred day simple moving average of $81.54.

Prestige Consumer Healthcare (NYSE:PBH - Get Free Report) last announced its quarterly earnings data on Thursday, August 7th. The company reported $0.95 EPS for the quarter, missing the consensus estimate of $1.01 by ($0.06). The company had revenue of $249.53 million for the quarter, compared to analyst estimates of $260.71 million. Prestige Consumer Healthcare had a return on equity of 12.69% and a net margin of 19.02%.The business's quarterly revenue was down 6.6% compared to the same quarter last year. During the same period last year, the business earned $0.90 EPS. Prestige Consumer Healthcare has set its FY 2026 guidance at 4.500-4.580 EPS. Equities analysts anticipate that Prestige Consumer Healthcare Inc. will post 4.5 EPS for the current year.

Wall Street Analysts Forecast Growth

PBH has been the subject of a number of research reports. Wall Street Zen lowered shares of Prestige Consumer Healthcare from a "buy" rating to a "hold" rating in a report on Saturday, August 9th. Canaccord Genuity Group dropped their price objective on shares of Prestige Consumer Healthcare from $105.00 to $100.00 and set a "buy" rating for the company in a report on Friday, August 8th. Finally, Royal Bank Of Canada upgraded shares of Prestige Consumer Healthcare to a "hold" rating in a report on Thursday, May 8th. Three analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to MarketBeat, Prestige Consumer Healthcare has an average rating of "Moderate Buy" and an average target price of $93.33.

Prestige Consumer Healthcare Company Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.